Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
67,515,045
-
Shares change
-
+153,987
-
Total reported value, excl. options
-
$3,921,152,772
-
Value change
-
+$8,866,404
-
Number of buys
-
92
-
Number of sells
-
-98
-
Price
-
$58.08
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q2 2015
228 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q2 2015.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,515,045 shares
of 71,941,794 outstanding shares and own 93.85% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (6,510,496 shares), VANGUARD GROUP INC (5,664,505 shares), Neuberger Berman Group LLC (5,329,155 shares), FRANKLIN RESOURCES INC (4,337,076 shares), BlackRock Fund Advisors (4,240,023 shares), BAMCO INC /NY/ (2,543,961 shares), STATE STREET CORP (2,409,903 shares), KALMAR INVESTMENTS INC /DE/ (2,052,423 shares), BlackRock Institutional Trust Company, N.A. (1,653,626 shares), and ROYAL BANK OF CANADA (1,583,622 shares).
This table shows the top 217 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.